Outcome MeasureOther

POMS

Profile of Mood States

2 Papers in Blossom

Clinical Thresholds

Low disturbance

Moderate

High disturbance

0200

Low disturbance

Score 0–50

Moderate

Score 51–100

High disturbance

Score 101–200

Outcome Data Across Studies

Reported results for POMS across 2 studies with quantitative data.

Outcome data across 3 study arm–timepoint observations
					SD
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer 2011Secondary	Psilocybin(experimental)	0	12	—	—	—
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer 2011Secondary	Active Niacin Placebo(active_comparator)	0	12	—	—	—
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA 2021Secondary	MDMA-assisted psychotherapy(experimental)	7	14	—	—	—

Papers Using POMS

Paywallindividual

Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA

In an open‑label study of 14 participants with alcohol use disorder, clinically administered MDMA produced no post‑acute mood declines ('Blue Mondays'); participants maintained positive mood in the week after dosing, reported improved sleep at 3‑ and 6‑month follow‑ups, and none sought illicit MDMA. These results support the safety and tolerability of therapeutic MDMA and suggest previously reported come‑downs are likely due to illicit sourcing and recreational settings rather than clinical use.

Published: December 13, 2021
Journal: Journal of Psychopharmacology
Authors: Sessa, B., Aday, J. S., Curran, H. V., Measham, F., Higbed, L., Nutt, D. J., O'Biren, S.

Open Accessindividual

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

This is the first (modern) double-blind placebo-controlled study (n=12) of psilocybin (14mg/70kg) for the treatment of (end-of-life) anxiety (and depression) related to cancer. Treatment led to a significant reduction in anxiety symptoms up to three months after treatment and improvements in depressive symptoms reached significance after six months.

Published: January 3, 2011
Journal: JAMA Psychiatry
Authors: Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., Greer, G. R.

Quick Facts

Full Name: Profile of Mood States
Domain: Other
Papers Indexed: 2
Score Range: 0–200
Interpretation: Lower = better
Unit: points

All Measures